Genmab — Januar 2018
-
Begge dag har der været pæn modstand i 1120´erne.
-
I dette område har eventuelle shortere ikke øget trykket.
-
Det ville ellers være oplagt, hvis man har grumme hensigter.
-
Jeg har lige løbet ned gennem alle dagens handler. Det ser virkelig spøjst ud med al den algoritmehandel mellem A/B´erne.
-
De fik i hvert fald igen bragt deres nettokøb i slutauktionen.
-
afhænger af JNJ den 23.
-
Henrik48...Jeg står nu bag disken i familiens butik. Det er en sjælden stille fredag.
-
Har brugt seks måneder på at træne nyt personale op. Nu er de begyndt at blive selvkørende. Det giver mig lidt luft til fritidsjobbet på PI.
-
Seeing Dara being used as example in "FDA Helps Streamline Approval Process for Supplemental Drug Indications" makes me feel comfortable about Dara processing speed within the FDA
-
Best of ASH 2017. Did the excitement over CAR T-cell therapies news live up to expectations? What new myeloma drugs and treatment paradigms are now on the horizon? Dr. Brian G.M. Durie explains the most significant findings presented at the 59th American Society of Hematology annual conference for patients, caregivers, and other members of the myeloma community. https://www.myeloma.org/videos/best-ash-2017
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind